In the News

1855 News Items found
Geneticist Michael Berger
In the Lab
In a new paper, a collaborative team of MSK experts reports how a novel tool will help researchers learn more about the role of inherited hereditary mutations.
Pamela R. Drullinsky
MSK’s Pamela Drullinsky, MD, a breast medical oncologist and Regional Care Network Medical Site Director of MSK Nassau, joined one of her patients on a recent segment on Noticiero Telemundo 47 for breast cancer awareness month.
Jianjiong Gao, Hongxin Zhang, Nikolaus Schultz, Debyani Chakravarty, and Sarah Suehnholz stand together on a terrace
Feature
OncoKB, a database developed and maintained by investigators at MSK, helps match patients with targeted therapies based on the mutations found in their tumors.
Memorial Sloan Kettering researchers Luc Morris and Nils Weinhold
Learn about recent research led by MSK physician-scientist Luc Morris, who is trying to better predict who will benefit from immunotherapy.
Man in surgical scrubs looks at reader
Learn how one man's determination to be a doctor took him on an incredible journey from working at a car wash in the Bronx to becoming a physician at Memorial Sloan Kettering Cancer Center, with the help of mentors and a world-class work ethic.
By switching from one cellular identity to another, lung cancer cells can evade targeted therapies. MSK scientists are trying to stop that from happening.
Memorial Sloan Kettering Cancer Center named to Fast Company's “Brands That Matter” list.
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.
Memorial Sloan Kettering thoracic surgeon Prasad Adusumilli
Researchers identify a biomarker that could predict which lung cancer patients will respond to chemotherapy.
Announcement
“We could not be more proud of this deserving group of the outstanding GSK students who have been recognized with fellowship support this academic year,” says GSK Dean Michael Overholtzer.